| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke
|
Han, Thang S.
|
|
|
53 |
1 |
p. 218-227
|
article
|
| 2 |
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
|
Vestal, Mark L.
|
|
|
53 |
1 |
p. 167-175
|
article
|
| 3 |
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series
|
Morton, Celia
|
|
|
53 |
1 |
p. 235-239
|
article
|
| 4 |
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19
|
Gülcü, Oktay
|
|
|
53 |
1 |
p. 88-95
|
article
|
| 5 |
Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity
|
Kille, Alexander
|
|
|
53 |
1 |
p. 1-9
|
article
|
| 6 |
Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation
|
Yuan, Shuai
|
|
|
53 |
1 |
p. 43-50
|
article
|
| 7 |
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19
|
Ichikawa, Junko
|
|
|
53 |
1 |
p. 118-122
|
article
|
| 8 |
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)
|
García de Guadiana-Romualdo, Luis
|
|
|
53 |
1 |
p. 103-112
|
article
|
| 9 |
ICODE: the international COVID-19 thrombosis biomarkers colloquium—novel soluble biomarkers: circulating cell-free nucleic acids and other molecules
|
Krauel, Krystin
|
|
|
53 |
1 |
p. 83-87
|
article
|
| 10 |
Impact of a pharmacist driven anticoagulation reversal program at a large academic medical center
|
Procopio, Gabrielle L.
|
|
|
53 |
1 |
p. 158-166
|
article
|
| 11 |
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
|
Corrochano, Mariana
|
|
|
53 |
1 |
p. 96-102
|
article
|
| 12 |
Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer
|
Chokshi, Sagar K.
|
|
|
53 |
1 |
p. 202-207
|
article
|
| 13 |
Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection
|
Koubaissi, Salwa A.
|
|
|
53 |
1 |
p. 231-234
|
article
|
| 14 |
Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma
|
Jain, Divyanu
|
|
|
53 |
1 |
p. 208-212
|
article
|
| 15 |
MicroRNA-29b reduces myocardial ischemia–reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathway
|
Li, Kunsheng
|
|
|
53 |
1 |
p. 123-135
|
article
|
| 16 |
Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event
|
Zapponi, Kiara C. S.
|
|
|
53 |
1 |
p. 30-42
|
article
|
| 17 |
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis
|
Mendoza, Pablo A.
|
|
|
53 |
1 |
p. 74-82
|
article
|
| 18 |
Overexpression of miR-1298 attenuates myocardial ischemia–reperfusion injury by targeting PP2A
|
Ouyang, Chun
|
|
|
53 |
1 |
p. 136-148
|
article
|
| 19 |
Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities
|
Anyfanti, Panagiota
|
|
|
53 |
1 |
p. 10-16
|
article
|
| 20 |
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction
|
Nicolas, Johny
|
|
|
53 |
1 |
p. 20-29
|
article
|
| 21 |
Practice patterns surrounding referral to a specialty venous thromboembolism (VTE) clinic: a retrospective review
|
Landry, Sarah
|
|
|
53 |
1 |
p. 176-181
|
article
|
| 22 |
Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
|
Fattorutto, Maurizio
|
|
|
53 |
1 |
p. 58-66
|
article
|
| 23 |
Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation
|
Lu, Xu
|
|
|
53 |
1 |
p. 191-201
|
article
|
| 24 |
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism
|
Yamashita, Yugo
|
|
|
53 |
1 |
p. 182-190
|
article
|
| 25 |
Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study
|
Le Mao, Raphael
|
|
|
53 |
1 |
p. 67-73
|
article
|
| 26 |
Rotational thromboelastometry and conventional coagulation tests in patients undergoing major cardiac or aortic surgery: a retrospective single-center cohort study
|
Keyl, Cornelius
|
|
|
53 |
1 |
p. 149-157
|
article
|
| 27 |
The clot thickens—enhanced integration of stroke and thrombosis training
|
Carlin, Stephanie
|
|
|
53 |
1 |
p. 17-19
|
article
|
| 28 |
The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature
|
Jacobs, Jeremy
|
|
|
53 |
1 |
p. 213-217
|
article
|
| 29 |
Transient endothelial injury and release of lupus anticoagulant in COVID-19
|
Trimaille, Antonin
|
|
|
53 |
1 |
p. 228-230
|
article
|
| 30 |
Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review
|
Sedhom, Ramy
|
|
|
53 |
1 |
p. 51-57
|
article
|
| 31 |
U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients
|
Kuno, Toshiki
|
|
|
53 |
1 |
p. 113-117
|
article
|
Journal description